Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L Cell
Open accessThe DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.
Abstract
Insulin resistance and type 2 diabetes mellitus are associated with impaired postprandial secretion of glucagon-like peptide-1 (GLP-1), a potent insulinotropic hormone. The direct effects of insulin and insulin resistance on the L cell are unknown. We therefore hypothesized that the L cell is responsive to insulin and that insulin resistance impairs GLP-1 secretion. The effects of insulin and insulin resistance were examined in well-characterized L cell models: murine GLUTag, human NCI-H716, and fetal rat intestinal cells. MKR mice, a model of chronic hyperinsulinemia, were used to assess the function of the L cell in vivo. In all cells, insulin activated the phosphatidylinositol 3 kinase-Akt and MAPK kinase (MEK)-ERK1/2 pathways and stimulated GLP-1 secretion by up to 275 ± 58%. Insulin resistance was induced by 24 h pretreatment with 10−7m insulin, causing a marked reduction in activation of Akt and ERK1/2. Furthermore, both insulin-induced GLP-1 release and secretion in response to glucose-dependent insulinotropic peptide and phorbol-12-myristate-13-acetate were significantly attenuated. Whereas inhibition of phosphatidylinositol 3 kinase with LY294002 potentiated insulin-induced GLP-1 release, secretion was abrogated by inhibiting the MEK-ERK1/2 pathway with PD98059 or by overexpression of a kinase-dead MEK1-ERK2 fusion protein. Compared with controls, MKR mice were insulin resistant and displayed significantly higher fasting plasma insulin levels. Furthermore, they had significantly higher basal GLP-1 levels but displayed impaired GLP-1 secretion after an oral glucose challenge. These findings indicate that the intestinal L cell is responsive to insulin and that insulin resistance in vitro and in vivo is associated with impaired GLP-1 secretion. Insulin is a novel secretagogue of the incretin hormone, glucagon-like peptide-1 (GLP-1), and L cell insulin resistance impairs heterologous secretagogue-induced GLP-1 secretion in vitro and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, GLP-1 and GIP mediate insulin secretion and concomitantly, insulin modulates GIP212 and GLP-1 release; the latter ocurring through the PI3K/Akt- and mitogen-activated protein kinase kinase (MAPKK or MEK)/ERK1/2 pathway.213”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [213]
Citations
Cites
1 retracted
Bi-directional Regulation of Brown Fat Adipogenesis by the Insulin Receptor
Entingh, A. J., Taniguchi, C. M., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303056200 · Cited by 59 · cited 2×
“Identification of mouse and human insulin receptor transcripts was based on primers and conditions reported to generate PCR products of 500 or 600 (isoform A)/636 (isoform B) bp, respectively (36, 37).”
MethodRetractedThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · cited 6×
“org Endocrinology, February 2009, 150(2):580–591”
BackgroundInfluentialVilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793 · cited 1×
“Given the demonstrated importance of endogenous GLP-1 release to the maintenance of normal insulin secretion and glucose homeostasis (47, 48), it is therefore somewhat paradoxical that postprandial GLP-1 release is decreased in subjects with type 2 diabetes and insulin resistance, independent of obesity (18–24).”
BackgroundSelf-citationGlucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
EISSELE, R., GÖKE, R., WILLEMER, S., HARTHUS, H. ‐., VERMEER, H., ARNOLD, R., & GÖKE, B. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01464.x · Cited by 654
Nauck, M. A., Heimesaat, M. M., Behle, K., Holst, J. J., Nauck, M. S., Ritzel, R., Hüfner, M., & Schmiegel, W. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8355 · Cited by 605
Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534 · cited 1×
“Interestingly, although GIP and PMA stimulate GLP-1 secretion through the activation of protein kinase A and protein kinase C isoenzymes, respectively (9, 70), recent studies demonstrated that these secretagogues can also activate the MEK-ERK1/2 pathway in other cell models (71, 72).”
BackgroundVilsbøll, T., Krarup, T., Sonne, J., Madsbad, S., Vølund, A., Juul, A. G., & Holst, J. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021873 · Cited by 528
Pandini, G., Frasca, F., Mineo, R., Sciacca, L., Vigneri, R., & Belfiore, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202766200 · Cited by 500 · cited 1×
“Identification of mouse and human insulin receptor transcripts was based on primers and conditions reported to generate PCR products of 500 or 600 (isoform A)/636 (isoform B) bp, respectively (36, 37).”
Method
Cited by
Items 101–199 of 199
Lai, F., Chen, Y., Lin, H.-M., Wang, X., Zhu, X., Li, Y., Xiao, H., & Cao, X. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.021 · Cited by 12
Insulin regulates glucagon-like peptide-1 secretion by pancreatic alpha cells
Liu, P., Song, J., Liu, H., Yan, F., He, T., Wang, L., Shen, H., Hou, X., & Chen, L. (2018) · Endocrine · doi:10.1007/s12020-018-1684-3 · Cited by 14
Stinson, S. E., Alzola, I. F. D. R., Hovendal, E. D. B., Lund, M. A. V., Fonvig, C. E., Holm, L. A., Jonsson, A. E., Frithioff‐Bøjsøe, C., Christiansen, M., Pedersen, O. B., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad728 · Cited by 13
“Interestingly, higher fasting concentrations and lower GLP-1 response to an oral glucose challenge has also been observed in a rodent model of chronic hyperinsulinemia (MKR mice) compared with control mice (40).”
BackgroundOminous Octet and Other Scary Diabetes Stories
Kelly, S. D., & Neary, S. L. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.11.002 · Cited by 23
Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells
Ma, L., Cao, X., Ye, X., Ye, J., & Sun, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s247251 · Cited by 13
14-3-3-zeta mediates GLP-1 receptor agonist action to alter α cell proglucagon processing
Holter, M. M., Phuong, D. J., Lee, I. S., Saikia, M., Weikert, L., Fountain, S., Anderson, E. T., Fu, Q., Zhang, S., Sloop, K. W., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn3773 · Cited by 14
Role of Incretin Hormones in Bowel Diseases
Zietek, T., Waldschmitt, N., & Rath, E. (2017) · Endocrine development · doi:10.1159/000475731 · Cited by 13
Liu, S., Huang, Y. W., Wu, C., Chiu, C., & Chiang, M. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf305410k · Cited by 12
Liu, S., Liu, R., Chiang, Y., Song, L., Li, X., Jin, T., & Wang, Q. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00328.2011 · Cited by 11
García-Martínez, J. M., Chocarro‐Calvo, A., la Vieja, A. D., & García‐Jiménez, C. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.07.020 · Cited by 11
Shimizu, K., Ono, M., Mikamoto, T., Urayama, Y., Yoshida, S., Hase, T., Michinaga, S., Nakanishi, H., Iwasaki, M., Terada, T., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202301594rr · Cited by 11
“55 Serum levels of GLP-1, a gut-derived incretin hormone secreted from intestinal L cells, and induction of glucose-stimulated insulin secretion 43 were similar between Ad- LPLAT10-and control Ad-treated mice.”
ResultHarada, K., Sakaguchi, H., Sada, S., Ishida, R., Hayasaka, Y., & Tsuboi, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.143 · Cited by 12
Gut T Cells Feast on GLP-1 to Modulate Cardiometabolic Disease
Tsai, S. J., Winer, S., & Winer, D. A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.002 · Cited by 11
Nakamori, H., Niimi, A., Mitsui, R., & Hashitani, H. (2024) · The Journal of Physiology · doi:10.1113/jp286258 · Cited by 10
Insulin-Regulated Glucagon-Like Peptide-1 Release from L Cells: Actin’ Out
Thurmond, D. C. (2009) · Endocrinology · doi:10.1210/en.2009-1178 · Cited by 9
O'Brien, R., Buckley, M. M., Kelliher, A., & O’Malley, D. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13631 · Cited by 10
Cheng, J.-J., Wei, W., Chen, C. C., Shiao, Y., Huang, N., Liao, C.-H., Wu, T.-H., Ueng, Y., & Liu, H. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106330 · Cited by 10
Checkpoint kinase 2 controls insulin secretion and glucose homeostasis
Chong, A. C. N., Vandana, J. J., Jeng, G., Li, G., Meng, Z., Duan, X., Zhang, T., Qiu, Y., Duran‐Struuck, R., Coker, K. E., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01466-4 · Cited by 12
Stat3-mTOR signaling mediates the stimulation of GLP-1 production induced by IL-27
Lei, G., Chen, L., Peng, M., Zeng, B., Yang, Q., Zhai, H., & Xu, G. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0124 · Cited by 8
Pan, L., Xu, M. J., Wang, Q., Zou, X., Han, Y., & Zhou, Z. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11541 · Cited by 8
Biancolin, A. D., Srikrishnaraj, A., Jeong, H., Martchenko, A., & Brubaker, P. L. (2022) · Endocrinology · doi:10.1210/endocr/bqac142 · Cited by 8
Self-citationBloch, O., Broide, E., Ben-Yehudah, G., Cantrell, D., Shirin, H., & Rapoport, M. J. (2015) · Journal of Diabetes Research · doi:10.1155/2015/561353 · Cited by 8
Doytcheva, P., Bächler, T., Tarasco, E., Marzolla, V., Engeli, M., Pellegrini, G., Stivala, S., Rohrer, L., Tona, F., Camici, G. G., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006441 · Cited by 7
Engineering-inspired approaches to study β-cell function and diabetes
Lewis, P. L., & Wells, J. M. (2021) · Stem Cells · doi:10.1002/stem.3340 · Cited by 8
Srivastava, S., & Singh, R. (2021) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.9.2.07 · Cited by 7
Alcohol Intoxication and the Postburn Gastrointestinal Hormonal Response
Idrovo, J., Shults, J. A., Curtis, B. J., Chen, M. M., & Kovacs, E. J. (2019) · Journal of Burn Care & Research · doi:10.1093/jbcr/irz083 · Cited by 7
Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment
Li, X., Liu, Y., Zhang, Z., Hai, W., Pan, Y., & Zhang, Y. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07197-z · Cited by 6
“GLP-1 is a small peptide composed of 30 or 31 amino acids and is primarily produced by L cells in the distal small intestine and colon [ 2 ].”
Pharmacogenetics of Glucagon-like-peptide-1 receptor in diabetes management
Kalinkova, M., Kadiyska, T., & Handjieva‐Darlenska, T. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e104481 · Cited by 6
“However, after multivariate analysis the data became insignificant (Lin et al. 2015).”
Narimani, B., Amini, M. R., Sheikhhossein, F., Akhgarjand, C., Gholizadeh, M., Askarpour, M., & Hekmatdoost, A. (2023) · Journal of Nutritional Science · doi:10.1017/jns.2023.115 · Cited by 7
“(41,44) Purslane, which contains a high amount of fl avonoids, might bene fi cially decrease CVD including high blood pressure.”
BackgroundGil‐Lozano, M., & Brubaker, P. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4_21 · Cited by 5
“…Janus-activated kinase/signal transducers and activators of transcription signaling pathway (Anini and Brubaker 2003 ), whereas the effects of insulin are mediated through the activation of the extracellular signal-regulated kinases and are dependent upon the presence of glucose (Lim et al. 2009 ).”
BackgroundSelf-citationGut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review
Tzeravini, E., Simati, S., Anastasiou, I. A., Dalamaga, Μ., & Kokkinos, A. D. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00687-7 · Cited by 8
“Additionally, medications such as metformin and colesevelam, which increase GLP-1 levels, may contribute to the heterogeneity observed across studies [80–82].”
Gagnon, J., & Brubaker, P. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16104-4_20 · Cited by 4
Self-citationMulherin, A. J., Oh, A., Kim, H., Grieco, A., Lauffer, L., & Brubaker, P. (2011) · Obesity and metabolism · doi:10.14341/2071-8713-5305 · Cited by 4
Self-citationSong, X., Zhou, L., Xu, H., Wang, F., Liang, G., Zhang, L., Huang, F., & Jiang, G. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-04926-0 · Cited by 4
Izbicka, E., & Streeper, R. T. (2023) · Pharmaceuticals · doi:10.3390/ph16070913 · Cited by 5
“Since IR and T2D are associated with the impaired postprandial secretion of GLP-1 [44,45], the endogenous activity of AZA might be beneficial in these conditions.”
BackgroundVranić, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00344.2010 · Cited by 7
“She then characterized the stimulatory effects of M1 agonist, of leptin, of the oleic acid derivative (OEA), and of insulin on GLP-1 release (5, 6, 110, 118).”
BackgroundCen, H. H., Botezelli, J. D., Wang, S., Noursadeghi, N., Jessen, N., Timmons, J. A., & Johnson, J. D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/556571 · Cited by 4
Gilijamse, P. W., Demirkıran, A., van Wagensveld, B. A., Ackermans, M. T., Romijn, J. A., Nieuwdorp, M., ter Horst, K. W., & Serlie, M. J. M. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2021.04.022 · Cited by 5
Peart, L. A., Draper, M., & Tarasov, A. I. (2024) · Peptides · doi:10.1016/j.peptides.2024.171243 · Cited by 5
13CO2 breath tests, a tool to assess intestinal and liver function in the ICU?
Vogt, J. A., Radermacher, P., & Georgieff, M. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283376739 · Cited by 4
Effects of Vagotomy and Fenugreek on Hyperlipidemia and Insulin Resistance
Khound, R. (2017) · Lincoln (University of Nebraska) · Cited by 3
Yang, W., Hao, C., Wang, N., Xie, J., Zhou, B., Yang, Z., Zheng, A., Wei, J., Li, C., Xie, C., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2661854 · Cited by 3
Model Based Analysis of Ethnic Differences in Type 2 Diabetes
Møller, J. B. (2012) · Cited by 2
Albaghlany, R. M., Shahsavani, M. B., Hoshino, M., Moosavi‐Movahedi, A. A., Ghasemi, Y., & Yousefi, R. (2023) · Biochimie · doi:10.1016/j.biochi.2023.10.020 · Cited by 2
Kistkins, S., Moser, O., Ankudovičs, V., Bļizņuks, D., Mihailovs, T., Lobanovs, S., Sourij, H., Pfeiffer, A. F. H., & Pīrāgs, V. (2024) · Endocrine Connections · doi:10.1530/ec-23-0529 · Cited by 3
“When L cells become resistant to insulin, it can lead to a decrease in the release of GLP-1 in response to various stimuli (49).”
BackgroundLee, S. P., Kuo, F. Y., Cheng, J., & Wu, M. C. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.86938 · Cited by 6
“Then, the effects of TQ on I-Rs were further identified in GLP-1 secreting cell line NCI-H716 cells in vitro [22].”
BackgroundTissue engineering a pancreatic substitute based on recombinant intestinal endocrine cells
Bara, H. (2008) · SMARTech Repository (Georgia Institute of Technology) · Cited by 2
Handley, D., Almansoori, S., Sato, M. S., Amin, H. A., Alsters, S., Chahal, H., Purkayastha, S., Murphy, K. G., van Haelst, M. M., le Roux, C. W., et al. (2023) · medRxiv · doi:10.1101/2023.05.22.23290347 · Cited by 1
Yang, Q.-Q., Qian, Q.-H., Zhang, W., Song, Y.-P., Huang, Q.-Y., Lu, X., Wang, T., Huang, Y., & Xu, D. (2026) · Environment & Health · doi:10.1021/envhealth.5c00540 · Cited by 1
Yoder, S. M. (2010) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Azarias, W. S., & Sinésio, L. E. M. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004820 · Cited by 1
Kheder, M. H. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122879 · Cited by 1
Lau, D. (2010) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(10)43003-8
From Enteroglucagon to the Glucagon-Like Peptides, GLP-1 and GLP-2
Brubaker, P. L. (2010) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(10)43017-8
Self-citationLee, S., Kim, J.-H., Shin, J.-A., Kim, E. S., Cho, J., Ko, S., Yoon, K., & Ahn, Y. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.01.012
Role of GLP-1 receptor agonists in endothelial function
Erdogdu, Ö. (2012) · Figshare
Molecular regulation of hormone secretion, growth and apoptosis of GLP-1-producing cells
Kappe, C. (2012) · Figshare
IDENTIFICATION AND CHARA CTERIZATION OF THE GLUCAGON-LIKE PEPTIDE-2 HORMONAL SYSTEM IN RUMINANTS
Taylor-Edwards, C. C. (2009) · UKnowledge (University of Kentucky)
Gagnon, J. (2013) · Library and Archives Canada (Government of Canada)
Whey protein: Effects on insulin secretion and intestinal health via intestinal peptides
Ney, D. M., & Boehler, C. J. (2011) · Nutrafoods · doi:10.1007/bf03223384
The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
Hsieh, J. (2012) · TSpace (University of Toronto)
van der Wielen, N., & van der (2016)
Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
Flock, G. B. (2012) · TSpace (University of Toronto)
Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer
Trivedi, S. (2011) · TSpace (University of Toronto)
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1
Poreba, M. (2011) · TSpace (University of Toronto)
Investigating the role of heatshock on diabetic wound healing
Contractor, T. (2017) · ChesterRep (University of Chester)
Surgical management of diabetes mellitus: future outlook (part 2)
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723250-60
Xu, E. (2012) · Corpus Université Laval (Université Laval)
Effects of passage through the digestive tract on incretin secretion: Before and after birth
Tomotaki, S., Araki, R., Motokura, K., Tomobe, Y., Yamauchi, T., Hanaoka, S., Tomotaki, H., Iwanaga, K., Niwa, F., Takita, J., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13447 · Cited by 1
Mulaik, M. W. (2013) · PubMed
Markovic, M. A. (2020) · TSpace (University of Toronto)
Modulation of muscle cell insulin receptor signalling, transcription and trafficking by insulin
Cen, H. H. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0401784 · Cited by 1
PREVENÇAO DO CANCER CERVICO UTERINO; FATORES PARA NAO REALIZAÇAO
Magalhães, A. W. D., & MEDEIROS, A. A. D. A. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004933
A INFLUÊNCIA DA LIRAGLUTIDA NOS RECEPTOR GLP-1 DURANTE O PROCESSO DE EMAGRECIMENTO
de Carvalho, R. A., Neto, V. F., Siqueira, R. D. M., de Carvalho, P. S. V., de Carvalho, C. S. V., Fróes, Y. N., Pavão, F. M. F. A., Filho, J. J. J. P., da Silva, D. F., & Silva, M. R. C. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004889
Armelin, P. V. D. A. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004898
VIVÊNCIA DE IDOSOS EM INSTITUIÇÃO DE LONGA PERMANÊNCIA EM JOÃO PESSOA - PB: RELATO DE EXPERIÊNCIA
Carvalho, M. D. S., Barbosa, L. C. D. C., Aranda, L. D., & de Holanda, V. M. V. M. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004928
Silva, A. C. D. O., de Carvalho, R. R., & Marques, A. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211104956
AVALIAÇÃO DA COBERTURA VACINAL DE CRIANÇAS MENORES DE 5 ANOS NO HAITI - 2016-2018
Bayard, C., Lexius, O., Ribeiro, M. D. N. D. S., dos Santos, E. R., & Melo, G. Z. D. S. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004852
SINDROME DE RAPUNZEL: TRICOBEZOAR GASTRODUODENAL GIGANTE
MEDEIROS, A. A. D. A., & Magalhães, A. W. D. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004918
BENEFÍCIOS DA AURICULOTERAPIA EM PACIENTES COM DORES CRÔNICAS
Cavalcante, F. V., Mendes, M. R. P., & Ferreira, P. D. D. S. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004817
Aguiar, G. E. D., Nani, M. C. B., Bani, G. M. A. C., & Nasser, T. F. (2021) · Editora Conhecimento Livre eBooks · doi:10.37423/211004906
(2016) · CRC Press eBooks · doi:10.1201/9781315368115-8
Investigating the genetics of equine endocrine dysfunction
Cash, C. M. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.238537
O’Malley, D. (2023) · Springer eBooks · doi:10.1007/978-3-031-25702-5_10
Hocaoğlu-Emre, F. S. (2023) · International Conference on Recent Academic Studies · doi:10.59287/as-proceedings.114
A Critical Analysis of Dietetics: Part 3, Dietary Ratios: Amino Acids, Fatty Acids, HormonesPreprint
Sedley, L. (2025) · Preprints.org · doi:10.20944/preprints202504.0717.v1
Kim, J., Lee, Y., Park, S.-H., Jang, Y., Park, J., Lee, J. K., Park, S., & Kwon, Y. (2025) · Journal of Medicinal Food · doi:10.1089/jmf.2025.k.0024 · Cited by 1
Glucagon-Like Peptide-1: The Role of Calcium in Gut-Glucose Axis
Foamkom, A.-I., Abdelhady, H. G., & Razzaque, M. S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-04357-3_10 · Cited by 1
Slow mechanisms for inhibiting eating: Appetite, satiety, and their control
Carr, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29218-7.00020-1
Pharmacogenetic Insights into Glucagon-Like Peptide-1 Receptor and Its Role in Diabetes Therapy
Davis, C., Taylor, L., & Moore, I. (2023) · Annals of Pharmacy Practice and Pharmacotherapy · doi:10.51847/qbaabzn70k
Nouveaux concepts dans la pharmacologie des récepteurs aux acides gras à chaîne courte FFA2 et FFA3
Moussaud, E. (2011) · theses.fr (ABES) · doi:10.70675/5dd666cfzdb67z4279z8b88z58fbf4e02231
“In enteroendocrine cells, the secretion of hormones that control the metabolism of glucose and fat, such as CCK, GLP-1 and glucose-dependent insulinotropic peptide (GIP) upon stimulation of GPR40 or GPR120 with medium- and long-chain fatty acids is mediated by a transient increase in cytosolic Ca2+ concentration (Hira…”
BackgroundInfluentialPrasad, R., Hewawansa, U. H. A. J., Dhital, S., Williamson, G., & Barber, E. (2026) · Future Foods · doi:10.1016/j.fufo.2026.101046
As, A., Балыкова, Л. А., Zaslavskaya, K. Y., Shohin, I. E., Геннадьевна, Б. Т., Zorina, L. A., Shcherbakova, V. S., Куркин, Д. В., Koryanova, K. N., Mishchenko, E. S., et al. (2026) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2026-14-4-387-409
Dieescting the effects of sweet tastants in the human gut-brain axis
Bryant, C. E. (2014) · Research Explorer (The University of Manchester) · Cited by 1
Metadata
- Authors
- Lim, G. E., Huang, G. J., Flora, N., LeRoith, D., Rhodes, C. J., & Brubaker, P. L.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- University of Chicago (US)
- Corresponding author
- Brubaker, Patricia L.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2009-02-01
- Volume
- 150
- Issue
- 2
- Pages
- 580-591
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- PMC
- PMC5393261
- OpenAlex
- W2010671489
- Cited by
- 200
- References
- 75
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 12 · 2022: 5 · 2021: 25 · 2020: 8 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 12 · 2015: 17 · 2014: 11 · 2013: 14 · 2012: 12
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrinology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050610, R01DK055267)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin, glucagon-like peptide-1, enteroendocrine L cells, insulin resistance, type 2 diabetes, phosphatidylinositol 3-kinase, Akt signaling, MEK/ERK1/2 pathway, GLP-1 secretion, hyperinsulinemia, glucose-dependent insulinotropic polypeptide, intestinal hormone secretion
- MeSH terms
- Animals, Cells, Cultured, Female, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Pregnancy, Receptor, Insulin, Signal Transduction, Rats, Wistar, Receptor, IGF Type 1, Mice, Knockout, Enteroendocrine Cells, Mice, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.